Member Info for JohnHenry

Hopefully u will get your full allotment. i expect it to be well oversubscribed.

retail need to get in early on primary bid

No chance

Avacta Group plc (AIM: AVCT), the developer of Affimer(R) biotherapeutics and reagents , announces in response to substantial institutional interest,

Has been for a while with Roche Abbot and Quotient

yes wave 2 but in the abc corrective phase.

imho techs will correct 50% of recent correction to around 160 p before wave C to test the 50 EMA then new highs.

Technicals are in a corrective phase. FIB 50 and confluence area 118-125p

How can they be clearing stock that hasnt even been sold or issued yet. The ATM facilities is used IF and when needed.

New overhang is the warrant holders selling. aimho

Bedwetters dumping shares.

Profit taking in Covid stocks plus TILS have the continuous overhangs to clear.

Because they know bedwetters will panic.

Rubbish, illogical comparison, Exact Sciences purchased a company with 1000 employees not just a platform.

Oldapache read the RELEVANT RNS they haven’t sold $20 m yet so how can’t it be a problem.

When the seller is out.

Taverham I suggest you Thoroughly reread once or twice.

The majority of the selling is the overhang from Quilter Cantors trying to clear however volume is dropping off.

Small Pharmaceutical and Biotech area entering a new dynamic phase with Investors having been DEAD for over 20 years.

A shocker from CEO, one of the most poorly judged behaviour from a CEO I’ve ever witnessed. Issuing a speeding on his own interview. CRAZY state of affairs.

Absolutely shocking behaviour from the CEO.